Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Cascades Inc (CADNF) Q4 2024 Earnings Call Highlights: Strong EBITDA Growth Amid Challenges

In This Article:

  • Revenue: Increased 6% year over year.

  • Consolidated EBITDA: $146 million, up 4% from Q3 and 20% year over year.

  • Containerboard EBITDA: $104 million, 17% margin, 16% increase from Q3.

  • Specialty Products EBITDA: Up 4% from Q3, 16% margin, 47% increase year over year.

  • Tissue EBITDA: $45 million, up 5% from Q3.

  • Net Loss Per Share: $0.13, compared to $0.57 loss last year and $0.01 earnings in Q3.

  • Adjusted Net Earnings Per Share: $0.25, compared to $0.05 last year and $0.27 in Q3.

  • Adjusted Cash Flow from Operations: $129 million, up from $103 million last year and $86 million in Q3.

  • Capital Investments: $148 million for the full year, forecasted $175 million for 2025.

  • Net Debt: Increased by $57 million in Q4, leverage at 4.2x.

Release Date: February 20, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • Cascades Inc (CADNF) reported a 6% year-over-year increase in sales for Q4 2024, driven by favorable selling prices and exchange rates.

  • Consolidated EBITDA increased by 20% year-over-year, reflecting stronger contributions from packaging activities.

  • The Containerboard segment saw a 16% sequential increase in EBITDA, marking the fourth consecutive quarter of improvement.

  • The Specialty Products business delivered solid results with a 9% year-over-year sales increase and a 47% improvement in EBITDA.

  • The company has implemented strategic initiatives to mitigate potential tariff impacts, including changes to raw material sourcing and production reallocation.

Negative Points

  • Cascades Inc (CADNF) reported a net loss per share of $0.13 for Q4 2024, compared to a net loss of $0.57 per share in the same period last year.

  • The Tissue business experienced a year-over-year EBITDA decrease of $16 million, mainly due to higher raw material costs.

  • Corporate activities saw an $11 million negative impact due to unfavorable exchange rate variations and higher health insurance costs for US employees.

  • The company faces potential risks from bilateral tariffs, which could impact approximately 15% of its revenues.

  • Net debt increased by $57 million in Q4, raising leverage to 4.2x, up from 3.4x at the end of 2023.

Q & A Highlights

Q: Recently, International Paper announced a large containerboard mill closure. Do you expect to see any other high-cost mills closing and additional capacity exiting the market going forward? A: Hugues Simon, President and CEO: We won't comment on competitors' actions, but we continuously monitor supply and demand. Currently, our order file is steady, reflecting seasonal volumes. However, potential tariffs could alter behaviors, and we are closely tracking the situation.